Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (697)	4/6/1999 4:46:00 PM
From: M. P. McNamara, Jr. M.D.	Read Replies (1) \| Respond to of 2001

Rick, thanks for the URL. I had actually been to the site about two weeks ago and had queried the database thru the UK server, but had searched on European Patents (EP) when I did it. I was able read the patent but was unable to save it as a file or print it. In any case, it was a good read. I found it interesting that the monoclonal antibody patent application is "a continuation, in part, of U.S. Application number 08/918,349 filed 8/26/97." Thus, they have obviously been working in this area for quite a while. Lockeed isn't the only company to have a "Skunkworks".